7h
Hosted on MSNEMA approves Takeda’s Takhzyro pre-filled pen option for HAEThe European Medicines Agency (EMA) has approved an additional 2 mL pre-filled pen option for subcutaneous administration of ...
The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...
| Avoid common pitfalls in EU orphan drug market access—learn how local expertise can help navigate pricing, reimbursement, ...
Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...
The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...
Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
One of the main challenges identified by the research was that, although the European Medicines Agency (EMA) approves new ...
After a momentous 2024, Culver City-based ImmunityBio Inc., the immunotherapy company founded and majority-owned by ...
Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results